Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 706 AL 720

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Rebassa JB, Capó T, Lillo J, Raïch I, Reyes-Resina I, Navarro G.

Int J Mol Sci. 2024 May 15;25(10):5378. doi: 10.3390/ijms25105378.

Decoding the role of the CCL2/CCR2 axis in Alzheimer's disease and innovating therapeutic approaches: Keeping All options open

Arfaei R, Mikaeili N, Daj F, Boroumand A, Kheyri A, Yaraghi P, Shirzad Z, Keshavarz M, Hassanshahi G, Jafarzadeh A, Shahrokhi VM, Khorramdelazad H.

Int Immunopharmacol. 2024 Jun 30;135:112328. doi: 10.1016/j.intimp.2024.112328. Epub 2024 May 25.

Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review

Arjmand S, Ilaghi M, Sisakht AK, Guldager MB, Wegener G, Landau AM, Gjedde A.

Basic Clin Pharmacol Toxicol. 2024 Aug;135(2):115-132. doi: 10.1111/bcpt.14035. Epub 2024 May 27.

Inhibiting the Aggregation of Aβ by Natural Product Molecules

Bai SC, Wang YC, Li XZ, Li G.

ChemMedChem. 2024 Sep 2;19(17):e202400223. doi: 10.1002/cmdc.202400223. Epub 2024 Jul 15.

Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer's Disease

Singh R, Panghal A, Jadhav K, Thakur A, Verma RK, Singh C, Goyal M, Kumar J, Namdeo AG.

Mol Neurobiol. 2024 Dec;61(12):10916-10940. doi: 10.1007/s12035-024-04256-8. Epub 2024 May 29.

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)

Feldman HH, Luchsinger JA, Léger GC, Taylor C, Jacobs DM, Salmon DP, Edland SD, Messer K, Revta C, Flowers SA, Jones KS, Koulman A, Yarasheski KE, Verghese PB, Venkatesh V, Zetterberg H, Durant J, Lupo JL, Gibson GE; ADCS BenfoTeam Study Group.

PLoS One. 2024 May 29;19(5):e0302998. doi: 10.1371/journal.pone.0302998. eCollection 2024.

The Role of Microglia with Mitochondrial Dysfunction and Its Therapeutic Prospects in Alzheimer's Disease

Li Y, Li T, Chen T, Li C, Yu W, Xu Y, Zeng X, Zheng F.

J Integr Neurosci. 2024 Apr 30;23(5):91. doi: 10.31083/j.jin2305091.

Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential

Lee D, Antonsdottir IM, Clark ED, Porsteinsson AP.

Expert Opin Pharmacother. 2024 May;25(7):791-799. doi: 10.1080/14656566.2024.2360069. Epub 2024 May 30.

Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease

Meur S, Mukherjee S, Roy S, Karati D.

Mol Neurobiol. 2024 Dec;61(12):10941-10955. doi: 10.1007/s12035-024-04257-7. Epub 2024 May 30.

Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD)

Venkatesan D, Muthukumar S, Iyer M, Babu HWS, Gopalakrishnan AV, Yadav MK, Vellingiri B.

J Biochem Mol Toxicol. 2024 Jun;38(6):e23741. doi: 10.1002/jbt.23741.

Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory

Fakih N, Fakhoury M.

J Psychiatr Pract. 2024 May 1;30(3):181-191. doi: 10.1097/PRA.0000000000000779.

Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs

Pramanik R, Dey A, Chakrabarty AK, Banerjee D, Narwaria A, Sharma S, Rai RK, Katiyar CK, Dubey SK.

J Ethnopharmacol. 2024 Oct 28;333:118402. doi: 10.1016/j.jep.2024.118402. Epub 2024 May 29.

Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives

Gucký A, Hamuľaková S.

CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3.

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents

Pereira M, Cruz MT, Fortuna A, Bicker J.

Drug Discov Today. 2024 Jul;29(7):104052. doi: 10.1016/j.drudis.2024.104052. Epub 2024 Jun 1.

Focus of endothelial glycocalyx dysfunction in ischemic stroke and Alzheimer's disease: Possible intervention strategies

Balistreri CR, Di Giorgi L, Monastero R.

Ageing Res Rev. 2024 Aug;99:102362. doi: 10.1016/j.arr.2024.102362. Epub 2024 Jun 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias